Raily Aesthetic Medicine International Holdings Limited
HKEX:2135.HK
0.137 (HKD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | |
|---|---|---|---|---|---|---|
| Revenue
| 99.179 | 110.358 | 78.686 | 113.987 | 117.25 | 109.784 |
| Cost of Revenue
| 64.107 | 66.218 | 53.542 | 60.403 | 77.798 | 65.271 |
| Gross Profit
| 35.072 | 44.14 | 25.143 | 53.584 | 39.452 | 44.512 |
| Gross Profit Ratio
| 0.354 | 0.4 | 0.32 | 0.47 | 0.336 | 0.405 |
| Reseach & Development Expenses
| 1.731 | 0 | 2.244 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 54.837 | 47.343 | 47.505 | 51.721 | 57.405 | 50.19 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 56.567 | 47.343 | 49.749 | 51.721 | 57.405 | 50.19 |
| Operating Income
| -21.495 | -3.203 | -24.606 | 1.863 | -17.953 | -5.678 |
| Operating Income Ratio
| -0.217 | -0.029 | -0.313 | 0.016 | -0.153 | -0.052 |
| Total Other Income Expenses Net
| -11.514 | 0.132 | -2.407 | 0.716 | -2.922 | -0.98 |
| Income Before Tax
| -33.01 | -3.071 | -27.013 | 2.579 | -20.874 | -6.658 |
| Income Before Tax Ratio
| -0.333 | -0.028 | -0.343 | 0.023 | -0.178 | -0.061 |
| Income Tax Expense
| 1.587 | 1.47 | -4.21 | 2.292 | -5.534 | -0.132 |
| Net Income
| -32.628 | -2.55 | -19.516 | 1.79 | -15.073 | -6.284 |
| Net Income Ratio
| -0.329 | -0.023 | -0.248 | 0.016 | -0.129 | -0.057 |
| EPS
| -0.068 | -0.005 | -0.041 | 0.004 | -0.031 | -0.013 |
| EPS Diluted
| -0.068 | -0.005 | -0.041 | 0.004 | -0.031 | -0.013 |
| EBITDA
| -6.977 | 11.209 | -10.873 | 15.09 | -8.471 | 2.354 |
| EBITDA Ratio
| -0.07 | 0.102 | -0.138 | 0.132 | -0.072 | 0.021 |